<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="991">
  <stage>Registered</stage>
  <submitdate>11/01/2006</submitdate>
  <approvaldate>11/01/2006</approvaldate>
  <actrnumber>ACTRN12606000017527</actrnumber>
  <trial_identification>
    <studytitle>Improving stroke recovery in Maori and Pacific people and their families</studytitle>
    <scientifictitle>A randomised controlled study to measure the effectiveness of an educational video compared to a goal setting exercise and to a control (written pamphlet) in the treatment of stroke to improve stroke recovery for Maori and Pacific people and their families.</scientifictitle>
    <utrn />
    <trialacronym>MAPSS</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Stroke</healthcondition>
    <conditioncode>
      <conditioncode1>Stroke</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Randomised controlled trial (multi centre).
Participants randomised to receive one of three interventions or a control.  Intervention A - Educational video lasting 80 minutes
Intervention B - goal setting exercise lasting 90 minutes
Intervention C - both the video and the goal setting exercise lasting 170 minutes
</interventions>
    <comparator>Control - written pamphlet will take 30 miutes to read</comparator>
    <control>Placebo</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Short form 36 physical component</outcome>
      <timepoint>Measured at 6 months and 12 months after stroke</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Carer strain Index</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mortality</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mental wellness (using Hua Oranga)</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Frenchay Activity Index</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Barthell Index</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Comorbidities (using Charlson Index)</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Discrimination (EDQ)</outcome>
      <timepoint>Measured at baseline, 6 months and 12 months after stroke.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Stroke using World Health Organistaion definition 'rapidly developing symptoms and/or signs of focal, and at times global, loss of cerebral function, with symptoms lasting longer than 24 hours or leading to death with no apparent cause other than that of vascualr originSelf idenitfied ethnicity as Maori, Samoan, Tongan, Cook Island Maori, Niuean, Fijian.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Can not give informed consentLiving within institution after strokeSubarachnoid haemorrhage.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Once informed consent from participant, researcher to contact Randomisation Coordinator (RC).  The RC will enter baseline information into a secure computerised randomisation programme which will assign that participant to a particular treatment group.  The RA will then provide the intervention and ask that the participant not inform subsequent researchers of the intervention he/she received</concealment>
    <sequence>Computerised programme</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/02/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>480</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Matire Harwood and Dr Harry McNaughton</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council of New Zealand</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Alan Barber</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr John Gommans</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Api Talemaitoga</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Mark Weatherall</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Will Taylor</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Professor Kathryn McPherson</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Multi Regional Ethics Commitee</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Matire Harwood and Dr Harry McNaughton</name>
      <address>c/o Medical Research Institute of New Zealand (MRINZ)
PO Box 10055
Wellington</address>
      <phone>+64 4 4729112</phone>
      <fax />
      <email>matire.harwood@mrinz.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Matire Harwood</name>
      <address>c/o Medical Research Institute of New Zealand (MRINZ)
PO Box 10055
Wellington</address>
      <phone>+64 4 4729112</phone>
      <fax />
      <email>matire.harwood@mrinz.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>